New Delivery for Penicillin Sodium For Inj. - Artesunate +sulformethoxine+ pyrimethamine tabs – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 1,000,000 tablets |
Supply Ability | 120,000,000 tablets/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Artesunate +sulformethoxine+ pyrimethamine tabs |
Specification | 100mg+525mg |
Description | A white tablets |
Standard | USP |
Package | 6+3’s/blister |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | AMK-A tablets is recommended for use for malaria treatment,especially for preventing malaria
caused Plasmodium falciparum that are resistant to chloroquine,also used in the treatment of cerebral malaria and emergency treatment of critical cases. administered as a single dose on D1,with the first dose of artesunate. |
Product detail pictures:
Related Product Guide:
Disease, Doctors, Drugs and Vitamins!
Medication & Dietary Supplement Interactions – What You Should Know about Drugs and Vitamins
As a way to ideal meet up with client's desires, all of our operations are strictly performed in line with our motto "High Top quality, Competitive Cost, Fast Service" for New Delivery for Penicillin Sodium For Inj. - Artesunate +sulformethoxine+ pyrimethamine tabs – KeMing Medicines, The product will supply to all over the world, such as: Philadelphia, Nigeria, Malta, The design, processing, purchasing, inspection, storage, assembling process are all in scientific and effective documentary process , increasing usage level and reliability of our brand deeply, which makes us become superior supplier of the four major product categories shell castings domestically and obtained the customer's trust well.
By May from Bulgaria - 2017.08.28 16:02
The factory can meet continuously developing economic and market needs, so that their products are widely recognized and trusted, and that's why we chose this company.
By Jessie from Somalia - 2018.02.08 16:45